730 filings
Page 4 of 37
8-K
sdx155sfrobucm 95
11 Feb 22
Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the Company’s Bacteriophage Development
3:04pm
8-K
jjwim3anz1pk7c78w zk
5 Jan 22
Regulation FD Disclosure
4:05pm
8-K
pkwls9z0tc6
2 Nov 21
Entry into a Material Definitive Agreement
5:29pm
8-K
a40s8
29 Oct 21
Innoviva, a significant Armata shareholder, also elected to participate
5:26pm
8-K
c0pv2
13 Aug 21
Armata Pharmaceuticals Announces Second Quarter Results and Provides
12:00am
8-K
mgcbzrtb cchq
4 Aug 21
Departure of Directors or Certain Officers
4:35pm
8-K
h980q h9ln4oyq
14 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
EFFECT
u8mbrqvx55cmrl2fbg0
21 May 21
Notice of effectiveness
12:15am
424B3
s4koa
20 May 21
Prospectus supplement
4:23pm
CORRESP
wshtk0azm3z8lw wkbul
18 May 21
Correspondence with SEC
12:00am
UPLOAD
29ok5lov3bbs3dg b3n
18 May 21
Letter from SEC
12:00am
8-K
6w6f w30zb
14 May 21
Armata Pharmaceuticals Announces First Quarter Results and Provides
4:18pm
DEFA14A
qqbbvbia
22 Apr 21
Additional proxy soliciting materials
12:00am